Crinetics Pharmaceuticals, Inc. (CRNX) Insider Trading

Name: Crinetics Pharmaceuticals, Inc. (CRNX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 1, 2026): Wendell Wierenga (Director): Disposition to Issuer of 116,146 shares, $9.87M.

Get alerted when insiders trade CRNX

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta